Literature DB >> 5414249

The RNA of toxoplasma gondii.

J S Remington, M M Bloomfield, E Russell, W S Robinson.   

Abstract

Mesh:

Substances:

Year:  1970        PMID: 5414249     DOI: 10.3181/00379727-133-34531

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


× No keyword cloud information.
  14 in total

1.  A role for activated macrophages in resistance to infection with Toxoplasma.

Authors:  J S Remington; J L Krahenbuhl; J W Mendenhall
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

2.  Detection of immunoglobulin M antibodies with antigen-tagged latex particles in an immunosorbent assay.

Authors:  J S Remington; W M Eimstad; F G Araujo
Journal:  J Clin Microbiol       Date:  1983-05       Impact factor: 5.948

3.  Protection against Toxoplasma gondii in mice immunized with Toxoplasma cell fractions, RNA and synthetic polyribonucleotides.

Authors:  F G Araujo; J S Remington
Journal:  Immunology       Date:  1974-10       Impact factor: 7.397

4.  Specific antibody-dependent killing of Toxoplasma gondii by normal macrophages.

Authors:  S E Anderson; S C Bautista; J S Remington
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

5.  An analysis of those components of Toxoplasma gondii responsible for delayed hypersensitivity reactions in mice.

Authors:  C H Lai; I R Tizard; P J Quinn; D G Ingram
Journal:  Immunology       Date:  1975-04       Impact factor: 7.397

6.  Dichotomy between macrophage activation and degree of protection against Listeria monocytogenes and Toxoplasma gondii in mice stimulated with Corynebacterium parvum.

Authors:  J E Swartzberg; J L Krahenbuhl; J S Remington
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

7.  In vitro and in vivo effects of doxycycline on Toxoplasma gondii.

Authors:  H R Chang; R Comte; J C Pechère
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

8.  In vitro induction of nonspecific resistance in macrophages by specifically sensitized lymphocytes.

Authors:  J L Krahenbuhl; J S Remington
Journal:  Infect Immun       Date:  1971-10       Impact factor: 3.441

9.  Effects of Corynebacterium parvum treatment and Toxoplasma gondii infection on macrophage-mediated cytostasis of tumour target cells.

Authors:  J L Krahenbuhl; L H Lambert; J S Remington
Journal:  Immunology       Date:  1976-12       Impact factor: 7.397

10.  In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii.

Authors:  H R Chang; J C Pechère
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.